How to buy Sandu Pharmaceuticals shares?

You can easily buy Sandu Pharmaceuticals shares in Kotak Neo by [opening a demat account](https://www.kotakneo.com/open-demat-account/) and getting the KYC documents verified online.

Sandu Pharmaceuticals Share Price

BSE

42.5

-1.10 (-2.52%)

BSE

BSE: 524703 | Pharmaceuticals | Small Cap | as on 05 Jun, 2026 • 03:29 PM IST

Buy

Sandu Pharmaceuticals Annualised Returns

1 Year

▼-18.92%

3 Years

▼-9.41%

5 Years

▼-2.73%

10 Years

▲4.01%

Sandu Pharmaceuticals Share Price Today

As of 6 Jun 2026, Sandu Pharmaceuticals share price is ₹42.5. The stock opened at ₹43.6 and had closed at ₹43.6 the previous day. During today’s trading session, Sandu Pharmaceuticals share price moved between ₹42.14 and ₹43.60, with an average price for the day of ₹42.87. Over the last 52 weeks, the stock has recorded a low of ₹30.00 and a high of ₹58.28. In terms of performance, Sandu Pharmaceuticals share price has increased by 7.6% over the past six months and has declined by 18.92% over the last year.

Sandu Pharmaceuticals Stock Performance

1W Return	1.19
1Y Return	-17.59
Today's Low	42.14
Prev. Close	43.60
Mkt Cap (Cr.)	41.06

1M Return	0.93
3Y Return	-26.02
52-Week High	58.28
Open	43.59
PE Ratio	23.22

6M Return	7.59
Today's High	43.6
52-Week Low	30
Face Value	10

Sandu Pharmaceuticals Share Price Chart

Sandu Pharmaceuticals Company background

Founded in: 1985

Sandu Pharmaceuticals Limited (SPL) was established in 1987. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.94, to partfinance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines Formulations, at the Goa plant in 199697. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.Company manufactures quality Ayurvedic products and has acquired a unique position and reputation as a leading enterprise in the field of Ayurved. During the year 2023, it opened several sales outlets started selling goods directly to distributors stockiest.

Sandu Pharmaceuticals Financial Highlights

For the full year FY2025–2026, revenue reached ₹67.36 crore and profit touched at ₹1.55 crore.

Sandu Pharmaceuticals SIP Returns Calculator

Monthly

Quarterly

₹5,000

Over the past

Total Investment of ₹3,00,000

Monthly SIP of ₹5,000 would have become ₹2,80,085 in 5 years with a gain of ₹-19,914 (-6.64%)

Start SIP

Sandu Pharmaceuticals Fundamental

Market Cap (in crs)

41.06

Face Value

Turnover (in lacs)

0.23

Key Metrics

Qtr Change %

27.08% Fall from 52W High

22.1

Dividend yield 1yr %

High in industry

1.9

Sandu Pharmaceuticals Key Financials

Loading chart...

Sandu Pharmaceuticals Quarterly Revenue


14.07 Cr	18.37 Cr	17.7 Cr	17.05 Cr	15.6 Cr

Sandu Pharmaceuticals Yearly Revenue


67.36 Cr	67.7 Cr	65.68 Cr

Sandu Pharmaceuticals Quarterly Net Profit/Loss


0.33 Cr	0.56 Cr	0.5 Cr	0.17 Cr	0.59 Cr

Sandu Pharmaceuticals Yearly Net Profit/Loss


1.55 Cr	1.46 Cr	1.52 Cr

Sandu Pharmaceuticals Technical Analysis

Moving Averages Analysis

42.5

Current Price

Bullish Moving Averages

Bearish Moving Averages

5 EMA

42.80

10 EMA

42.30

12 EMA

42.10

20 EMA

41.50

26 EMA

41.10

50 EMA

39.80

100 EMA

39.20

200 EMA

41.10

Delivery & Volume

Loading chart...

Delivery Volume %

Day

92.50%

Week

74.70%

Month

46.30%


Day Rs	495 Rs	535 Rs
Week Rs	2491 Rs	3334 Rs
Month Rs	4866 Rs	10521 Rs

Resistance & Support

42.75

Pivot

Resistance

First Resistance

43.35

Second Resistance

44.21

Third Resistance

44.81

Support

First Support

41.89

Second support

41.29

Third Support

40.43

Relative Strength Index

55.22

Money Flow Index

87.65

MACD

1.04

MACD Signal

0.82

Average True Range

3.04

Average Directional Index

34.71

Rate of Change (21)

1.43

Rate of Change (125)

7.08

Sandu Pharmaceuticals Peer comparison

Compare


Mangalam Drugs and Organics Ltd.	28.50 +0.01 (+0.04%)▲	45.11	22.8	95	28.49	-0.90%	-3.26%	11.11%	-65.24%	-72.74%	0.00%	-1.02	48.08	0.43
Roopa Industries Ltd.	49.50 +1.48 (+3.08%)▲	38.93	38.1	66.9	48.02	-3.94%	-9.42%	11.24%	-23.49%	7.87%	0.00%	450.00	48.08	2.21
Lasa Supergenerics Ltd.	7.91 +0.21 (+2.73%)▲	39.63	5.67	14.2	7.70	-4.81%	-1.13%	-20.26%	-39.39%	-66.90%	0.00%	-1.16	48.08	0.80
ANG Lifesciences India Ltd.	29.19 +1.19 (+4.25%)▲	38.12	17.63	39.7	28.00	6.88%	6.61%	3.22%	0.00%	-60.50%	0.00%	-8.06	48.08	0.61
Rajnish Wellness Ltd.	0.44 -0.01 (-2.22%)▼	44.68	0.39	1.26	0.45	0.00%	-10.20%	-36.23%	-52.17%	-96.93%	0.00%	-7.33	48.08	0.44
Goldline Pharmaceutical Ltd.	45.25 +2.29 (+5.33%)▲	43.44	41.76	60	42.96	-6.59%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00	48.08	2.16

Sandu Pharmaceuticals Shareholding Pattern

Promoter

37.8%

Public

62.2%

Sandu Pharmaceuticals Latest News

18 MAY 2026

Sandu Pharmaceuticals - 524703 - Compliances-Reg.24(A)-Annual Secretarial Compliance

07 MAY 2026

Sandu Pharmaceuticals - 524703 - Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner, Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT, Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As Per Physical Verification Of Goods.